<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00196079</url>
  </required_header>
  <id_info>
    <org_study_id>506</org_study_id>
    <nct_id>NCT00196079</nct_id>
  </id_info>
  <brief_title>The ASPECT Study - Asian Paclitaxel-Eluting Stent Clinical Trial</brief_title>
  <official_title>The ASPECT Study - Asian Paclitaxel-Eluting Stent Clinical Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Cook Group Incorporated</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Cook Group Incorporated</source>
  <brief_summary>
    <textblock>
      The ASPECT study is an Asian multicenter, randomized, controlled, triple-blinded study
      designed to evaluate the ability of the Cook Incorporated Paclitaxel Eluting Supra G Coronary
      Stent to reduce restenosis in the coronary artery.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>February 2000</start_date>
  <completion_date>August 2001</completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Angiographic in-stent % diameter at follow-up.</measure>
  </primary_outcome>
  <secondary_outcome>
    <measure>Major adverse events</measure>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Total lesion revascularization</measure>
  </secondary_outcome>
  <enrollment>177</enrollment>
  <condition>Coronary Artery Disease</condition>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Coronary stent</intervention_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patient must be eligible to undergo planned treatment of a single de novo lesion in a
             native coronary artery.

          -  Patient must be an acceptable candidate for coronary artery bypass surgery.

          -  Patient must have given signed informed consent.

          -  Patient agrees to return at one month for an office visit to assess cardiovascular
             status and at 4-6 months for an office visit to assess cardiovascular status and for a
             diagnostic angiogram.

        Exclusion Criteria:

          -  Patient is less than 18 years old.

          -  Patient has history of bleeding diathesis or coagulopathy or will refuse blood
             transfusions.

          -  The patient is simultaneously participating in another investigative interventional
             cardiovascular device or drug study.

          -  Patient has known hypersensitivity or contraindication to aspirin, Clopidogrel, or
             stainless steel, or a sensitivity to contrast dye that.

          -  Patient is pregnant.

          -  Patient has other medical condition that may cause the patient to be non-compliant
             with the protocol, confound the results or is associated with limited life expectancy.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Seung Jung Park, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Asan Medical Center</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Contact Sponsor</name>
      <address>
        <city>Bloomington</city>
        <state>Indiana</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>January 2012</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>September 12, 2005</study_first_submitted>
  <study_first_submitted_qc>September 12, 2005</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 20, 2005</study_first_posted>
  <last_update_submitted>January 30, 2012</last_update_submitted>
  <last_update_submitted_qc>January 30, 2012</last_update_submitted_qc>
  <last_update_posted type="Estimate">February 1, 2012</last_update_posted>
  <responsible_party>
    <name_title>April Lavender, RAC, Vice President for Regulatory Affairs</name_title>
    <organization>Cook</organization>
  </responsible_party>
  <keyword>coronary artery</keyword>
  <keyword>stenosis</keyword>
  <keyword>drug eluting stent</keyword>
  <keyword>stent</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Coronary Artery Disease</mesh_term>
    <mesh_term>Myocardial Ischemia</mesh_term>
    <mesh_term>Coronary Disease</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Paclitaxel</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

